Background: Reduced bone mineral density (BMD) is a frequent comorbidity observed in people living with HIV (PLHIV).
Objective: The aim of the study is to determine the prevalence and associated factors of reduced bone mineral density (BMD) among men with suppressed viral load taking antiretroviral therapy.
Methods: The study was conducted as a cross-sectional design between January to April 2019.